{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:20:14Z","timestamp":1764588014047},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2019,10,15]]},"DOI":"10.2169\/internalmedicine.2864-19","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T22:03:41Z","timestamp":1561586621000},"page":"3039-3043","source":"Crossref","is-referenced-by-count":4,"title":["Immunoglobulin Light Chain Amyloidosis with Severe Liver Dysfunction Accompanied by Factor X Deficiency"],"prefix":"10.2169","volume":"58","author":[{"given":"Yong-mei","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Miyabe","sequence":"additional","affiliation":[{"name":"Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumito","family":"Abe","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaya","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Nara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokohama City University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiteru","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Cellular and Organ Pathology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): the natural history in 80 patients. Am J Med 85: 73-80, 1988."},{"key":"2","unstructured":"2. Gertz MA, Kyle RA. Hepatic amyloidosis: clinical appraisal in 77 patients. Hepatology 25: 118-121, 1997."},{"key":"3","unstructured":"3. McPherson RA, Onstad JW, Ugoretz RJ, et al. Coagulopathy in amyloidosis: combined deficiencies of factor X and IX. Am J Hematol 3: 225-235, 1977."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gatel A. AL amyloidosis combined with acquired factor V deficiency. Ann Intern Med 128: 604-605, 1998.","DOI":"10.7326\/0003-4819-128-7-199804010-00031"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Glenner GG. Factor X deficiency and systemic amyloidosis. N Engl J Med 297: 108-109, 1977.","DOI":"10.1056\/NEJM197707142970211"},{"key":"6","unstructured":"6. Greipp PR, Kyle RA, Bowie EJW. Factor X deficiency in amyloidosis: a critical review. Am J Hematol 11: 443-450, 1981."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mumford AD, Donnell JO, Gillmore JD, et al. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br J Haematol 110: 454-460, 2000.","DOI":"10.1046\/j.1365-2141.2000.02183.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Tashiro H, Shirasaki R, Watanabe M, et al. Direct factor X sequestration by systemic amyloid light-chain amyloidosis. Clin Case Rep 6: 513-515, 2018.","DOI":"10.1002\/ccr3.1398"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Desikan KR, Dhodapkar MV, Hough A, et al. Incidence and impact of light chain-associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leuk Lymphoma 27: 315-319, 1997.","DOI":"10.3109\/10428199709059685"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shimazaki C, Hata H, Iida S, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. Intern Med 57: 181-187, 2018.","DOI":"10.2169\/internalmedicine.9206-17"},{"key":"11","unstructured":"11. Buck FS, Koss MN. Hepatic amyloidosis: morphologic differences between systemic AL and AA types. Hum Pathol 22: 904-907, 1991."},{"key":"12","unstructured":"12. Park MA, Mueller PS, Kyle RA, et al. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore) 82: 291-298, 2003."},{"key":"13","unstructured":"13. Cibeira MT, Sanchorawala V, Seldin DC, et al. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood 118: 4346-4352, 2011."},{"key":"14","unstructured":"14. Gertz MA. Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol 88: 416-425, 2013."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Breems DA, Sonneveld P, de Man RA, et al. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion. Br J Haematol 72: 181-185, 2004.","DOI":"10.1046\/j.0902-4441.2003.00200.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Dispenzieri A, Gertz MA, Buadi F. What do I need to know about immunoglobulin light chain (AL) amyloidosis? Blood Rev 26: 137-157, 2012.","DOI":"10.1016\/j.blre.2012.03.001"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Girnius S, Seldin DC, Skinner M, et al. Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease. Haematologica 94: 1029-1032, 2009.","DOI":"10.3324\/haematol.2008.001925"},{"key":"18","unstructured":"18. Elnegouly M, Specht K, Zoller H, et al. Liver transplantation followed by autologous stem cell transplantation for acute liver failure caused by AL amyloidosis. Case report and review of the literature. Ann Hepatol 15: 592-597, 2016."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2864-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T03:34:25Z","timestamp":1571456065000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/58\/20\/58_2864-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,15]]},"references-count":18,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2864-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,15]]}}}